CLNE vs CLOV
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 02, 2026
CLNE
CLOV
Investment Advisor Scores
CLOV
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CLNE | CLOV | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.8966 | 37.7358 | CLNE |
| PEG Ratio | 4.7217 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 3.7% | 55.6% | CLOV |
| Earnings Growth | 512.0% | 0.0% | CLNE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 72.4/100 | 47.8/100 | CLNE |
| Profit Margin | -21.3% | -0.7% | CLOV |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | HOLD | CLNE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CLNE
NeutralMixed signals - no dominant trend phase, RSI 66
CLOV
MarkupPrice above SMA50, rising 50-day trend (2.8% over 20 days), RSI 60
Fundamentals Snapshot
| Metric | CLNE | CLOV |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 569.7 | 27.6 |
| Trailing P/E | — | 493.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.5% |
| Gross Margin | 0.3% | 0.2% |
| Operating Margin | 0.0% | 0.0% |
| EPS | -0.35 | 0.01 |
| Dividend Yield | — | — |